News & Insights
Welcome to Bellberry’s blog. Here we publish commentary, updates, feature posts, and thought leadership on research ethics, regulation, participant experience, and system change. Discover what’s happening across the research and ethics landscape in Australia and beyond.
CT:IQ and ACTA Working Closely Together – Literally!
Given ACTA’s and CT:IQs complementary clinical trials sector-boosting focus, and that ACTA is a CT:IQ founding partner, and that CT:IQ held its launch symposium at ACTA’s Trial of the Year awards event, the ACTA Central Team were never going to say “no” to CT:IQ’s newly appointed Program Director, Leanne Weekes, when she asked if she […]
Read More
AusBiotech 2018
Brisbane 31 October – 2 November 2018 The annual AusBiotech conference has brought together Australian and international biotech leaders and stakeholders for more than three decades, creating a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally. AusBiotech is dedicated to consolidating this growth, […]
Read More
Christmas and New Year 2018/19
The last HREC meeting of 2018 will be on 19th December 2018, and the first meeting for 2019 will be on 2 January. From 2nd January meetings will be held every Wednesday evening for the remainder of the year. Bellberry hold eight regular HREC meetings per month and meetings are held every Wednesday evening. […]
Read More
Bellberry at AHHMS
Oct 10 – 12, Melbourne The AHHMS Annual General and Scientific Meeting was this year attended by Trina O’Donnell, Bellberry Operations Manager. The event was titled ‘Collecting and using Big Data – machines, artificial intelligence, epidemiology, precision medicine & health economics’ and Professor Alan Lopez AC presented the keynote address. Trina reported that the meeting […]
Read More
Bellberry Board Member Awarded Pharmacists Highest Honour
Leading Australian pharmacist and Bellberry board member, Emeritus Professor Lloyd Sansom, has been awarded one of the profession’s highest international honours, the International Pharmaceutical Federation’s (FIP) André Bédat Award. The award is given in recognition of an outstanding contribution to pharmaceutical practice, and is awarded every 2 years. Lloyd joined Bellberry as a board member […]
Read More
Join us at ARCS 2018!
21-23 August, Sydney We’re back at ARCS again this year co-exhibiting with our colleagues from PRAXIS Australia. Come and meet the team including CEO Kylie Sproston, Operations Manager Trina O’Donnell, Quality Manager Alison Barr and our two Operations and Support Officers Sally Sims and Tess Penglis. We’re here to answer any questions you may have […]
Read More
CT:IQ Latest Steering Committee Members
Last month CanTeen became the latest organisation to join the CT:IQ Steering Committee. Bringing an important perspective, CanTeen help young people cope with cancer in their family and provide specialist youth-specific treatment teams and have young people affected by cancer guiding the organisation at every level. CanTeen are one of the many organisations that have […]
Read More
Operations and Support Officers
In April this year Bellberry recruited two new Operations and Support Officers, Sally Sims and Tess Penglis. The main purpose of this role is to act as a triage service for new studies and to prepare HREC meeting agendas and to support the Committee meeting process. Sally will also talk through any application queries with […]
Read More
New Quality Manager
Bellberry are delighted to announce that we have appointed a Quality Manager to the growing Bellberry team. Alison Barr joined us in this role on the 14th May 2018. Alison has been in the position of Research Governance Officer at Northern Adelaide Local Health Network (22 sites and incorporating the Lyell McEwan) and the Central […]
Read More
CT:IQ Launch
CT:IQ will be formally launched by Minister Hunt and Minister Cash on Wednesday 16 May at the Royal Melbourne Hospital from 10.30am. This event is a collaborative effort and will launch CT:IQ, celebrate the ACTA Clinical Trial of the Year Awards and launch the NHMRC consumer engagement campaign. This will be followed by a CT:IQ […]
Read More
Launch of Exciting New Australian Clinical Trials Initiative, CT:IQ!
We are delighted to announce that Bellberry, ACTA, NHMRC CTC and The George Institute have formed a consortium ‘Clinical Trials: Impact & Quality (CT:IQ)’. The consortium’s mission is “to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of […]
Read More
ACTA Trial of the Year Awards 2018
If you are a current ACTA (Australian Clinical Trials Alliance) member and you know of a network or group that published the primary results of a high-impact trial in 2017 (either electronically or in print), ACTA encourage you to read the award guidelines and consider nominating the trial for the 2018 Trial of the Year […]
Read More
Revised Clinical Trials Handbook Now Available
The TGA have recently released the revised Australian clinical trial handbook and it is now available on their website. The Handbook has been updated to reflect current practice. The TGA have also consolidated information from the following previous clinical trials guidance documents: Access to unapproved therapeutic goods – Clinical trials in Australia Australian Clinical Trial […]
Read More
Potential Elimination of Cervical Cancer Globally
Bellberry Board Member Professor Ian Frazer AC writes in The Guardian about the potential eradication of cervical cancer.
Read More
New Programme Manager
Bellberry has two objectives: to protect the welfare of human research participants and to improve the quality, efficiency and effectiveness of research. In 2017 we worked with a number of partner organisations to imagine a structure to address the question of Continuous Improvement in the Australian Clinical Research sector. Our founding co-partners include the Australian […]
Read More
Human Research Ethics Committees
Discover how Bellberry's committees operate and maintain the highest ethical standards in research.
Learn More
Monitoring & Quality
Learn about Bellberry's continuous improvement and oversight processes that ensure accountability.
Learn More
Grant Activities
See how Bellberry reinvests in research education and participant-focused initiatives.
Learn More